Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

In this online program based on a series of CLL Webinars experts discuss evidence-based best practices in using BTK inhibitors to treat patients with CLL. Watch the on-demand Webcast and download the slides now.

Share

Program Content

Activities

CLL BTKi Therapy: FAQ Part 1
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2020

Expires: September 16, 2021

CLL BTKi Therapy: FAQ Part 2
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2020

Expires: September 15, 2021

CLL BTKi Therapy: FAQ Part 3
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2020

Expires: September 16, 2021

Activities

CLL New Horizons With BTKi
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors
Congratulations: You achieved a completion on 04/09/2022

Activities

Prognostic Testing in CLL
Prognostic Marker Testing in Treatment-Naive Patients With CLL—Still Important
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2020

Expires: September 21, 2021

MRD Evaluation in CLL
Considering the Role of MRD Evaluation for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2020

Expires: September 28, 2021

Noncovalent BTKi
Overcoming BTK Resistance in CLL With Noncovalent BTK Inhibitors—Where We Are
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2020

Expires: September 24, 2021

Activities

<i>EP</i>: BTK Inhibitors in CLL
ExpressPoints Chronic Lymphocytic Leukemia: New Horizons with BTK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

BCR Pathway and BTK
Overview of the BCR Pathway and BTK in Tumor Development
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

Future Directions for BTKi
BTK Inhibitors: Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

BTK Inhibitors in TN CLL
BTK Inhibitors in Treatment-Naive CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

BTK Inhibitors in RR CLL
BTK Inhibitors in Relapsed/Refractory CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca